MedTech

Irish medtech scores €15m AI partnership with Novartis

Deciphex uses AI to interrogate tissue sections from biopsies to accelerate workflows and improve patient turnaround time and diagnostic accuracy

Deciphex chief executive Donal O’Shea. Deciphex uses AI to interrogate tissue sections from biopsies to accelerate workflows and improve patient turnaround time and diagnostic accuracy. Picture: Fergal Phillips

Irish medtech firm Deciphex has signed a collaboration agreement with Novartis, the pharma giant, to develop artificial intelligence solutions to aid drug discovery and development.

No financial details of the partnership have been publicly disclosed but industry spruces estimated it to be worth around €15 million.

The news comes as Deciphex is preparing for a return to capital markets with a plan to raise around €20 million.

The collaboration with Novartis is centred on creating ...